David Nagler serves as Executive at ARYx Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Nagler has executed 10 insider transactions totaling $432.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 20, 2018 involved selling 4,700 shares valued at $212.7K.
David Nagler currently holds 4,700 shares of ARYx Therapeutics, Inc. (ARYX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Nagler has been a net seller of ARYX stock. They have purchased $0 and sold $432.7K worth of shares.
David Nagler's most recent insider trade was on Jun 20, 2018, when they sold 4,700 shares at $45.25 per share.
Get notified when new Form 4 filings are submitted
| $2.19 |
| Discretionary |
| Jun 20, 2018 | BOLD | $13.8K | Sale | 300 | $46.02 | Discretionary |
| Jun 20, 2018 | BOLD | $657 | Option Exercise | 300 | $2.19 | Discretionary |
| Sep 27, 2017 | BOLD | $112.5K | Sale | 3,750 | $30.00 | Discretionary |
| Sep 27, 2017 | BOLD | $8.2K | Option Exercise | 3,750 | $2.19 | Discretionary |
| Sep 15, 2017 | BOLD | $8.2K | Option Exercise | 3,750 | $2.19 | Discretionary |
| Sep 15, 2017 | BOLD | $93.8K | Sale | 3,750 | $25.00 | Discretionary |
| Dec 21, 2009 | ARYX | $0 | Gift | 1,250 | $N/A | Discretionary |
| Dec 21, 2009 | ARYX | $0 | Gift | 1,000 | $N/A | Discretionary |